Abstract:Transforming growth factor-β (TGF-β) family members, which include TGF-βs, activins, and bone morphogenetic proteins (BMPs), elicit their multifunctional effects by binding to and complex formation of type I and type II serine/threonine kinase receptors (see Fig. 1). Each family member signals via distinct combinations of type I and type II receptors, both of which are required for signaling. Upon formation of the heteromeric receptor complex, the type I receptor is phosphorylated by the type II receptor kinase. Phosphorylation occurs predominantly in a region rich in glycine and serine residues (GS domain) in the juxtamembrane domain of the type I receptor, which possibly leads to a conformational change and thereby activates the type I receptor kinase (see Fig. 1) (, , ). The activated type I receptor propagates the signal downstream through transient interaction with, and phosphorylation of, particular Smoeand mad related protein (Smad) molecules (, , ). Certain Smads are phosphorylated directly by activated type I receptors in a differential manner; they are therefore termed pathway-restricted Smads. Whereas Smad2 and Smad3 act in TGF-β and activin pathways, Smad1, Smad5, and Smad8 are thought to act in BMP pathways. Phosphorylation occurs at the two most C-terminal serine residues in a conserved C-terminal Ser-Ser-X-Ser motif (see Fig. 2). Pathway-restricted Smads oligomerize with Smad4, which acts as a common mediator in TGF-β, activin, and BMP signaling. After translocation to the nucleus, the oligomers interact with DNA directly, or in complex with other DNA-binding proteins, and control transcription of target genes (see Figs. 1 and 2). Recently, inhibitory Smads, Smad6, and Smad7, have been identified that antagonize TGF-β family signaling (). Open image in new window Fig. 1. TGF-β signaling through Smad proteins. A hypothetical signal transduction pathway for TGF-β family members through their serine/threonine kinase receptors and downstream effector molecules of the Smad family, is depicted. Open image in new window Fig. 2. Functional domains in Smad proteins. Type I receptor-induced phosphorylation of pathway-restricted Smads may induce an unfolding of the N-and C-terminal domains (shown on left side), allowing heteromeric complex formation and transcriptional activation mediated by C-terminal domain and direct DNA-binding via N-terminal domain (shown on right side). The phospho-acceptor site of type I receptor kinase is indicated. The conserved regions in the N-terminal domain (MH1 domain) and C-terminal domain (MH2 domain), are indicated by black and hatched boxes, respectively.

Identification of Receptors and Smad Proteins Involved in Activin Signals in Human Epidermal Keratinocytes.

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7

Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7

Characterization of Type I Receptors for Transforming Growth Factor-β and Activin

Activin A induces a non-fibrotic phenotype in smooth muscle cells in contrast to TGF-β

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.

Eccrine sweat glands: expression of transforming growth factor-beta and bone morphogenetic protein type I receptors and their intracellular signalling Smad proteins.

Identification of Smad2, a Human Mad-related Protein in the Transforming Growth Factor Β Signaling Pathway

Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.

Characterization of in vivo phosphorylation of activin type II receptor.

Expression of Type I and Type IB Receptors for Activin in Midgestation Mouse Embryos Suggests Distinct Functions in Organogenesis

Overexpression of Smad2 Reveals Its Concerted Action with Smad4 in Regulating TGF- β-Mediated Epidermal Homeostasis

Expression Of Tgf-Beta Related Smad Proteins In Human Epithelial Skin Tumors

Phosphorylation of Smad Signaling Proteins by Receptor Serine/threonine Kinases.

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

TGF-β signaling by Smad proteins

Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses

Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation.

Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin